DEF: T2 Biosystems Seeks Stockholder Approval for Reverse Stock Split to Maintain Nasdaq Listing

T2 Biosystems is asking shareholders to approve a reverse stock split, with a ratio between 1-for-10 and 1-for-100, to regain compliance with Nasdaq's minimum bid price requirement.

Summary

• T2 Biosystems is holding a special meeting on March 3, 2025, to seek stockholder approval for a reverse stock split of its common stock.
• The proposed reverse stock split ratio will be between 1-for-10 and 1-for-100, with the exact ratio to be determined by the Board of Directors.
• The primary reason for the reverse stock split is to increase the company's stock price to meet Nasdaq's minimum bid price requirement of $1.00 per share and avoid delisting.
• The company received a delisting notice from Nasdaq on December 12, 2024, due to its stock price falling below $1.00 for 30 consecutive days.
• As of January 7, 2025, there were 28,045,417 shares of common stock outstanding.
• The reverse stock split will not change the total number of authorized shares, which will remain at 400,000,000, but will reduce the number of outstanding shares.
• The board believes a higher stock price could attract investors, retain employees, and improve the company's overall credibility.
• The reverse stock split will affect all stockholders uniformly, except for fractional shares, which will be paid out in cash based on the closing price on the day before the split.
• The company's board has the authority to abandon the reverse stock split if it is no longer in the best interest of the company.

Sentiment

Score: 5

Explanation: The document is neutral in tone, presenting the facts of the reverse stock split proposal. While the company is facing delisting, the proposed action is a standard response, and the document does not express undue optimism or pessimism.

Positives

• The reverse stock split is intended to help the company maintain its listing on the Nasdaq Capital Market.
• A higher stock price could attract more investors and increase trading volume.
• The reverse stock split could improve the company's ability to attract and retain employees.
• The company believes that continued listing on the Nasdaq Capital Market provides overall credibility to an investment in their stock.
• The reverse stock split will not affect any stockholders percentage ownership interests in the company, except to the extent that the reverse stock split results in any of our stockholders owning a fractional share.

Negatives

• There is no guarantee that the reverse stock split will result in a sustained increase in the stock price.
• The market price of the stock after the split may not rise in proportion to the reduction in the number of shares.
• The reverse stock split could negatively impact the market price of the stock if investors view it unfavorably.
• The liquidity of the stock could be adversely affected by the reduced number of shares outstanding.
• The company may still be delisted from Nasdaq even if the reverse stock split is implemented.

Risks

• The reverse stock split may not result in a sustained increase in the per share price of the common stock.
• The market price of the common stock may not rise in proportion to the reduction in the number of shares.
• The reverse stock split may not increase the level of investment in the common stock by institutional investors.
• The company may not be able to maintain the minimum bid price of $1.00 per share required by Nasdaq.
• Nasdaq may delist the common stock prior to the vote at the Special Meeting.
• The liquidity of the common stock could be adversely affected by the reduced number of shares outstanding.
• The total market capitalization of the common stock after implementation of the reverse stock split may be lower than before the reverse stock split.

Future Outlook

The company intends to use the reverse stock split to regain compliance with Nasdaq listing requirements and potentially attract more investors. The board will decide whether and when to implement the split based on market conditions and other factors. The company may conduct equity offerings in the future.

Management Comments

• The Board of Directors believes that the reverse stock split is our best means of ensuring compliance with the $1.00 per share of Common Stock minimum bid price requirement for continued listing on The Nasdaq Capital Market and avoid delisting.
• The Board of Directors believes that a higher stock price, which may be achieved through a reverse stock split, could help generate investor interest in the Company and help attract, retain, and motivate employees.
• The Board of Directors believes that some potential employees are less likely to work for the Company if we have a low stock price or are no longer listed on the Nasdaq Capital Market, regardless of size of our overall market capitalization.

Industry Context

The reverse stock split is a common strategy for companies facing delisting from major exchanges due to low stock prices. This action is aimed at maintaining the company's visibility and credibility in the market, which is crucial for attracting investors and maintaining access to capital.

Comparison to Industry Standards

• Many companies facing similar delisting threats have implemented reverse stock splits to regain compliance with exchange listing requirements.
• For example, companies like BioSpecifics Technologies Corp. and Titan Pharmaceuticals have previously used reverse stock splits to maintain their Nasdaq listings.
• The specific ratio of the reverse stock split (between 1-for-10 and 1-for-100) is within the typical range seen in similar situations.
• The decision to allow the board to determine the exact ratio provides flexibility, which is a common practice in these situations.

Stakeholder Impact

• Shareholders will experience a reduction in the number of shares they own, but their percentage ownership will remain the same, except for fractional shares.
• Employees may benefit from a higher stock price, which could improve morale and retention.
• The company's ability to raise capital may be improved if the reverse stock split is successful in maintaining the Nasdaq listing.
• Customers and suppliers may not be directly impacted by the reverse stock split.

Next Steps

• Stockholders will vote on the proposed reverse stock split at the Special Meeting on March 3, 2025.
• If approved, the Board of Directors will determine the exact reverse stock split ratio and implement the split.
• The company will notify stockholders of the effective date of the reverse stock split and provide instructions for exchanging stock certificates, if applicable.

Key Dates

Keywords

reverse stock split, Nasdaq, delisting, minimum bid price, stock price, common stock, shareholder meeting, T2 Biosystems, listing requirements